Sistemic, NHS Scotland Developing Biomarkers for Diabetes-related Sight Loss | GenomeWeb

NEW YORK (GenomeWeb News) – Sistemic today announced an agreement with NHS Scotland to develop biomarkers for the early detection of diabetic retinopathy and infective keratitis.

Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.